DEMECLOCYCLINE

DEMECLOCYCLINE was reported 228 times

DEMECLOCYCLINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PARANEOPLASTIC RASH 8 0.2857
1 ANTI A ANTIBODY 1 0.1250
2 NON-SMALL CELL LUNG CANCER STAGE II 1 0.0526
3 BLOOD ELECTROLYTES INCREASED 5 0.0427
4 ANTIDIURETIC HORMONE ABNORMALITY 2 0.0238
5 BROWN-SEQUARD SYNDROME 1 0.0147
6 RAPID CORRECTION OF HYPONATRAEMIA 3 0.0120
7 MENTAL STATUS CHANGES POSTOPERATIVE 1 0.0094
8 NON-CARDIOGENIC PULMONARY OEDEMA 6 0.0057
9 THYROID PAIN 1 0.0056
10 RENAL TUBULAR DYSFUNCTION 3 0.0053
11 RETICULOCYTOSIS 1 0.0047
12 MUSCLE OEDEMA 1 0.0046
13 DIABETES INSIPIDUS 11 0.0046
14 AUTOIMMUNE NEPHRITIS 1 0.0045
15 NEPHROGENIC DIABETES INSIPIDUS 5 0.0043
16 LUNG ADENOCARCINOMA METASTATIC 1 0.0043
17 ILIAC ARTERY OCCLUSION 1 0.0036
18 FEMORAL ARTERY OCCLUSION 1 0.0032
19 TUMOUR MARKER ABNORMAL 1 0.0030
20 SOFT TISSUE INFLAMMATION 1 0.0030
21 OSMOTIC DEMYELINATION SYNDROME 2 0.0027
22 QRS AXIS ABNORMAL 2 0.0026
23 METASTASES TO STOMACH 1 0.0026
24 BIOPSY BONE MARROW 1 0.0021
25 PERIPHERAL ARTERY STENOSIS 1 0.0021
26 PULMONARY VALVE INCOMPETENCE 3 0.0021
27 METASTASES TO ABDOMINAL CAVITY 1 0.0020
28 BLADDER MASS 1 0.0020
29 RETROPERITONEAL LYMPHADENOPATHY 1 0.0019
30 COATING IN MOUTH 1 0.0019
31 BLOOD SODIUM INCREASED 5 0.0019
32 METASTASES TO KIDNEY 1 0.0018
33 DILATATION ATRIAL 2 0.0017
34 STRIDOR 5 0.0017
35 LUNG ADENOCARCINOMA 5 0.0017
36 MITRAL VALVE CALCIFICATION 1 0.0016
37 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
38 ILEAL PERFORATION 1 0.0015
39 ORAL MUCOSAL DISCOLOURATION 1 0.0015
40 MUCOSAL DRYNESS 3 0.0015
41 ELECTROCARDIOGRAM ST-T CHANGE 1 0.0014
42 HYPERNATRAEMIA 7 0.0014
43 NEUTROPENIC SEPSIS 10 0.0014
44 AORTIC VALVE SCLEROSIS 1 0.0014
45 CAUDA EQUINA SYNDROME 1 0.0013
46 NEUROLOGICAL DECOMPENSATION 3 0.0013
47 INTERVERTEBRAL DISC SPACE NARROWING 1 0.0012
48 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
49 HYPERAMMONAEMIA 6 0.0012
50 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
51 LUNG HYPERINFLATION 1 0.0012
52 NON-SMALL CELL LUNG CANCER METASTATIC 1 0.0011
53 BLOOD CREATINE INCREASED 5 0.0011
54 METASTASES TO ADRENALS 1 0.0011
55 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
56 NON-SMALL CELL LUNG CANCER 5 0.0010
57 SKIN OEDEMA 1 0.0010
58 DECUBITUS ULCER 8 0.0010
59 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
60 BONE MARROW OEDEMA 1 0.0010
61 BONE NEOPLASM 1 0.0009
62 PRODUCT NAME CONFUSION 1 0.0009
63 METASTASES TO MENINGES 2 0.0009
64 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
65 TOXIC ENCEPHALOPATHY 4 0.0008
66 TRANSITIONAL CELL CARCINOMA 1 0.0008
67 TUMOUR PAIN 1 0.0008
68 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
69 HYPONATRAEMIA 41 0.0007
70 ALVEOLITIS 1 0.0007
71 AORTIC VALVE INCOMPETENCE 3 0.0007
72 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
73 OSTEOSCLEROSIS 1 0.0006
74 INTERMITTENT CLAUDICATION 1 0.0006
75 HISTOPLASMOSIS DISSEMINATED 1 0.0006
76 LYMPHOCYTE COUNT DECREASED 11 0.0006
77 ACUTE SINUSITIS 1 0.0006
78 BLOOD CHLORIDE INCREASED 1 0.0006
79 HYPOMAGNESAEMIA 8 0.0006
80 BURNS SECOND DEGREE 1 0.0006
81 SCLERODERMA 2 0.0005
82 ESSENTIAL HYPERTENSION 1 0.0005
83 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
84 ADRENAL DISORDER 1 0.0005
85 ATROPHY 1 0.0005
86 EARLY SATIETY 1 0.0005
87 PURULENCE 1 0.0005
88 CONCOMITANT DISEASE PROGRESSION 1 0.0005
89 HYPOPHYSITIS 1 0.0005
90 OSTEOLYSIS 1 0.0005
91 CONGESTIVE CARDIOMYOPATHY 2 0.0005
92 JAW FRACTURE 1 0.0005
93 EXPOSED BONE IN JAW 1 0.0005
94 AGRANULOCYTOSIS 8 0.0004
95 GASTRITIS EROSIVE 2 0.0004
96 PERFORMANCE STATUS DECREASED 2 0.0004
97 BLOOD SODIUM DECREASED 8 0.0004
98 RADIUS FRACTURE 1 0.0004
99 HUMERUS FRACTURE 2 0.0004
100 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
101 HYPERPARATHYROIDISM SECONDARY 1 0.0004
102 ILEOSTOMY 1 0.0004
103 VENTRICULAR DYSFUNCTION 1 0.0004
104 TRICUSPID VALVE INCOMPETENCE 3 0.0004
105 GASTROINTESTINAL STROMAL TUMOUR 1 0.0004
106 ABDOMINAL MASS 1 0.0004
107 DIABETIC COMA 1 0.0004
108 NEUTROPHIL COUNT ABNORMAL 1 0.0004
109 METABOLIC ENCEPHALOPATHY 1 0.0003
110 REBOUND ACID HYPERSECRETION 1 0.0003
111 DIASTOLIC DYSFUNCTION 1 0.0003
112 PNEUMONIA VIRAL 1 0.0003
113 BREAST ENLARGEMENT 1 0.0003
114 PEPTIC ULCER 1 0.0003
115 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
116 NEOPLASM RECURRENCE 1 0.0003
117 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
118 RASH MACULO-PAPULAR 6 0.0003
119 CHRONIC SINUSITIS 1 0.0003
120 MITRAL VALVE INCOMPETENCE 3 0.0003
121 THYROID MASS 1 0.0003
122 PROSTATOMEGALY 1 0.0003
123 POLYDIPSIA 1 0.0003
124 HAEMATOCRIT DECREASED 5 0.0003
125 MENTAL STATUS CHANGES 7 0.0003
126 AZOTAEMIA 1 0.0003
127 MYASTHENIA GRAVIS 2 0.0002
128 NEUTROPHIL COUNT DECREASED 10 0.0002
129 PERIPHERAL ISCHAEMIA 1 0.0002
130 DYSURIA 9 0.0002
131 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
132 SENSATION OF FOREIGN BODY 2 0.0002
133 BUNDLE BRANCH BLOCK LEFT 1 0.0002
134 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
135 POOR PERIPHERAL CIRCULATION 1 0.0002
136 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
137 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
138 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
139 DIVERTICULUM INTESTINAL 1 0.0002
140 INTENTIONAL DEVICE MISUSE 1 0.0002
141 LUNG INFILTRATION 2 0.0002
142 THIRST 4 0.0002
143 BLOOD BILIRUBIN INCREASED 6 0.0002
144 HYPOTHYROIDISM 7 0.0002
145 LUMBAR VERTEBRAL FRACTURE 1 0.0002
146 SYNOVIAL CYST 1 0.0002
147 NEPHROGENIC ANAEMIA 1 0.0002
148 HYPOCALCAEMIA 4 0.0002
149 PRODUCT PRESCRIBING ERROR 5 0.0002
150 DRUG PRESCRIBING ERROR 4 0.0002
151 FAECAL INCONTINENCE 1 0.0002
152 APHAGIA 1 0.0002
153 GUILLAIN-BARRE SYNDROME 1 0.0002
154 ENCEPHALOPATHY 5 0.0002
155 HOSPICE CARE 2 0.0002
156 LEUKOPENIA 10 0.0002
157 KLEBSIELLA INFECTION 1 0.0002
158 PATHOLOGICAL FRACTURE 1 0.0002
159 PERIPHERAL VASCULAR DISORDER 1 0.0002
160 NYSTAGMUS 1 0.0002
161 STRESS FRACTURE 1 0.0002
162 METASTASES TO BONE 3 0.0002
163 FAECALOMA 1 0.0002
164 BLOOD GLUCOSE FLUCTUATION 2 0.0002
165 STEVENS-JOHNSON SYNDROME 4 0.0002
166 NECROSIS 1 0.0002
167 HEART RATE ABNORMAL 1 0.0002
168 SKIN TOXICITY 1 0.0002
169 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
170 HYPOVOLAEMIA 1 0.0002
171 ENERGY INCREASED 1 0.0002
172 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
173 INGUINAL HERNIA 1 0.0002
174 SPINAL OPERATION 2 0.0002
175 LARYNGEAL OEDEMA 1 0.0002
176 PIGMENTATION DISORDER 1 0.0002
177 SCOLIOSIS 1 0.0002
178 ACUTE RESPIRATORY FAILURE 3 0.0002
179 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
180 PULMONARY CONGESTION 2 0.0002
181 COLITIS ISCHAEMIC 1 0.0001
182 ULCER HAEMORRHAGE 1 0.0001
183 OEDEMA PERIPHERAL 18 0.0001
184 RESPIRATION ABNORMAL 1 0.0001
185 JOINT EFFUSION 1 0.0001
186 PAIN IN JAW 4 0.0001
187 HAND FRACTURE 1 0.0001
188 EATING DISORDER 3 0.0001
189 RED BLOOD CELL COUNT DECREASED 4 0.0001
190 GRAFT VERSUS HOST DISEASE 1 0.0001
191 BLOOD CREATININE INCREASED 9 0.0001
192 INTENTIONAL UNDERDOSE 1 0.0001
193 PSYCHIATRIC SYMPTOM 1 0.0001
194 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
195 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
196 STOMATITIS 8 0.0001
197 ACIDOSIS 1 0.0001
198 PERICARDIAL EFFUSION 3 0.0001
199 BLOOD DISORDER 1 0.0001
200 FRUSTRATION TOLERANCE DECREASED 1 0.0001
201 MUSCLE DISORDER 1 0.0001
202 BACK DISORDER 2 0.0001
203 DYSPHONIA 7 0.0001
204 BLOOD UREA INCREASED 2 0.0001
205 SPINAL OSTEOARTHRITIS 1 0.0001
206 ATRIAL FIBRILLATION 11 0.0001
207 RESPIRATORY RATE INCREASED 1 0.0001
208 HAEMOLYTIC ANAEMIA 1 0.0001
209 HAEMARTHROSIS 1 0.0001
210 MYOSITIS 1 0.0001
211 EXOSTOSIS 1 0.0001
212 IRON DEFICIENCY ANAEMIA 1 0.0001
213 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
214 APPENDICITIS 1 0.0001
215 DEFORMITY 1 0.0001
216 EPISTAXIS 8 0.0001
217 PHOTOPHOBIA 2 0.0001
218 LACERATION 1 0.0001
219 ARTERIOSCLEROSIS 1 0.0001
220 INFUSION RELATED REACTION 7 0.0001
221 DEHYDRATION 14 0.0001
222 INCREASED APPETITE 2 0.0001
223 LIVER FUNCTION TEST ABNORMAL 3 0.0001
224 THERAPY CHANGE 1 0.0001
225 BODY TEMPERATURE DECREASED 1 0.0001
226 INABILITY TO AFFORD MEDICATION 1 0.0001
227 SPINAL FRACTURE 2 0.0001
228 CARDIAC FAILURE 8 0.0001
229 EMPHYSEMA 1 0.0001
230 NEUTROPHIL COUNT INCREASED 1 0.0001
231 EUPHORIC MOOD 1 0.0001
232 HYPERBILIRUBINAEMIA 1 0.0001
233 PULMONARY HYPERTENSION 2 0.0001
234 TRANSFUSION 1 0.0001
235 FULL BLOOD COUNT ABNORMAL 1 0.0001
236 INJECTION SITE NODULE 1 0.0001
237 SYNCOPE 9 0.0001
238 TRANSAMINASES INCREASED 2 0.0001
239 MALNUTRITION 1 0.0001
240 INTESTINAL PERFORATION 1 0.0001
241 BLOOD CALCIUM DECREASED 1 0.0001
242 INTERNAL HAEMORRHAGE 1 0.0001
243 CONVULSION 5 0.0001
244 MYOCARDITIS 1 0.0001
245 NEOPLASM 1 0.0001
246 HYPERKALAEMIA 3 0.0001
247 ACUTE KIDNEY INJURY 13 0.0001
248 PLATELET COUNT DECREASED 9 0.0001
249 BLOOD IRON DECREASED 1 0.0001
250 ATAXIA 1 0.0001
251 NEUROPATHY PERIPHERAL 8 0.0001
252 HYPERLIPIDAEMIA 1 0.0001
253 BURSITIS 1 0.0001
254 ADRENAL INSUFFICIENCY 1 0.0001
255 NO THERAPEUTIC RESPONSE 1 0.0001
256 CARDIOMEGALY 1 0.0001
257 INJECTION SITE EXTRAVASATION 1 0.0001
258 GENERALISED OEDEMA 1 0.0001
259 ILEUS 1 0.0001
260 COLITIS 3 0.0001
261 MUSCLE ATROPHY 1 0.0001
262 HYPOPHAGIA 2 0.0001
263 ANOREXIA 1 0.0001
264 HIATUS HERNIA 1 0.0001
265 PLATELET COUNT INCREASED 1 0.0001
266 ANHEDONIA 2 0.0001
267 ORAL CANDIDIASIS 1 0.0001
268 IMMUNE SYSTEM DISORDER 1 0.0001
269 JAUNDICE 2 0.0001
270 SINUS CONGESTION 1 0.0001
271 SKIN LESION 2 0.0001
272 HUNGER 1 0.0001
273 PANCYTOPENIA 4 0.0001
274 MASS 1 0.0001
275 THROMBOCYTOPENIA 8 0.0001
276 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
277 SEASONAL ALLERGY 1 0.0001
278 SINUS TACHYCARDIA 1 0.0001
279 PARALYSIS 1 0.0001
280 HYPERTHYROIDISM 1 0.0001
281 BONE PAIN 4 0.0001
282 RENAL INJURY 2 0.0001
283 PULMONARY MASS 1 0.0001
284 NEUTROPENIA 9 0.0001
285 ECONOMIC PROBLEM 1 0.0001
286 OSTEOPENIA 1 0.0001
287 CHRONIC KIDNEY DISEASE 5 0.0001
288 INSURANCE ISSUE 1 0.0001
289 PHARYNGEAL OEDEMA 1 0.0001
290 HYPOKALAEMIA 3 0.0001
291 MUSCULOSKELETAL CHEST PAIN 1 0.0001
292 EJECTION FRACTION DECREASED 1 0.0001
293 MENINGIOMA 1 0.0001
294 CYANOSIS 1 0.0001
295 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
296 CYSTITIS 2 0.0001
297 SCIATICA 1 0.0001
298 CONFUSIONAL STATE 10 0.0001
299 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
300 CONSTIPATION 13 0.0001
301 FLUID RETENTION 3 0.0001
302 HEPATIC ENZYME INCREASED 4 0.0001
303 URINARY TRACT INFECTION 10 0.0001
304 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
305 ASTHENIA 22 0.0001
306 HAEMOGLOBIN DECREASED 6 0.0001
307 NEOPLASM PROGRESSION 2 0.0001
308 ORTHOSTATIC HYPOTENSION 1 0.0001
309 METASTASES TO LIVER 1 0.0001
310 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
311 OSTEOMYELITIS 1 0.0001
312 RESPIRATORY FAILURE 4 0.0001
313 END STAGE RENAL DISEASE 1 0.0001
314 CHEST PAIN 10 0.0001
315 HEPATIC STEATOSIS 1 0.0001
316 FEELING JITTERY 1 0.0001
317 PULMONARY FIBROSIS 1 0.0001
318 LOWER LIMB FRACTURE 1 0.0001
319 DISEASE PROGRESSION 6 0.0001
320 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
321 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
322 BONE MARROW FAILURE 1 0.0000
323 WITHDRAWAL SYNDROME 2 0.0000
324 ABDOMINAL PAIN 11 0.0000
325 PNEUMONIA 15 0.0000
326 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
327 TOOTH DISORDER 1 0.0000
328 GLOSSODYNIA 1 0.0000
329 PULMONARY OEDEMA 2 0.0000
330 ORAL PAIN 1 0.0000
331 SNEEZING 1 0.0000
332 ABDOMINAL PAIN UPPER 9 0.0000
333 SEIZURE 5 0.0000
334 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
335 ANAEMIA 8 0.0000
336 DIARRHOEA 27 0.0000
337 PRESYNCOPE 1 0.0000
338 OSTEONECROSIS OF JAW 1 0.0000
339 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
340 AGEUSIA 1 0.0000
341 PNEUMONIA ASPIRATION 1 0.0000
342 ABDOMINAL PAIN LOWER 1 0.0000
343 HEPATITIS 1 0.0000
344 DECREASED APPETITE 9 0.0000
345 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
346 SPEECH DISORDER 2 0.0000
347 APPLICATION SITE ERYTHEMA 1 0.0000
348 PANCREATITIS 2 0.0000
349 RENAL FAILURE 5 0.0000
350 CARDIAC FAILURE CONGESTIVE 3 0.0000
351 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
352 HAEMATOCHEZIA 2 0.0000
353 PROCEDURAL PAIN 1 0.0000
354 FEELING COLD 1 0.0000
355 WOUND 1 0.0000
356 TARDIVE DYSKINESIA 1 0.0000
357 INTENTIONAL DOSE OMISSION 1 0.0000
358 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
359 ANGINA PECTORIS 1 0.0000
360 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
361 BACK PAIN 8 0.0000
362 URINARY INCONTINENCE 1 0.0000
363 CORONARY ARTERY DISEASE 1 0.0000
364 EMOTIONAL DISORDER 1 0.0000
365 FEMUR FRACTURE 1 0.0000
366 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
367 BONE DENSITY DECREASED 1 0.0000
368 HEAD INJURY 1 0.0000
369 METABOLIC ACIDOSIS 1 0.0000
370 FEBRILE NEUTROPENIA 2 0.0000
371 VISUAL ACUITY REDUCED 1 0.0000
372 BLOOD PRESSURE DECREASED 2 0.0000
373 DIZZINESS 15 0.0000
374 FUNGAL INFECTION 1 0.0000
375 URINARY RETENTION 1 0.0000
376 HYPOTENSION 6 0.0000
377 TYPE 2 DIABETES MELLITUS 1 0.0000
378 HEART RATE DECREASED 1 0.0000
379 HYPERTENSION 6 0.0000
380 LYMPHADENOPATHY 1 0.0000
381 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
382 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
383 THERAPY INTERRUPTED 2 0.0000
384 MOBILITY DECREASED 2 0.0000
385 DRUG EFFECT INCOMPLETE 1 0.0000
386 MALAISE 12 0.0000
387 DYSGEUSIA 2 0.0000
388 SEPSIS 3 0.0000
389 HEPATIC FUNCTION ABNORMAL 1 0.0000
390 DYSPNOEA EXERTIONAL 1 0.0000
391 MUSCULAR WEAKNESS 3 0.0000
392 PYREXIA 9 0.0000
393 PERIPHERAL SWELLING 4 0.0000
394 DRUG INTERACTION 4 0.0000
395 PSORIATIC ARTHROPATHY 1 0.0000
396 ANXIETY 7 0.0000
397 LUNG NEOPLASM MALIGNANT 1 0.0000
398 OSTEOPOROSIS 1 0.0000
399 TREATMENT FAILURE 2 0.0000
400 TREMOR 4 0.0000
401 FALL 8 0.0000
402 RHABDOMYOLYSIS 1 0.0000
403 POLLAKIURIA 1 0.0000
404 RENAL IMPAIRMENT 2 0.0000
405 OSTEOARTHRITIS 1 0.0000
406 LOSS OF CONSCIOUSNESS 3 0.0000
407 SEPTIC SHOCK 1 0.0000
408 MENTAL DISORDER 1 0.0000
409 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
410 THROAT IRRITATION 1 0.0000
411 FATIGUE 17 0.0000
412 SKIN DISCOLOURATION 1 0.0000
413 HYPERSENSITIVITY 4 0.0000
414 CARDIAC DISORDER 2 0.0000
415 PRODUCT USE ISSUE 4 0.0000
416 ARRHYTHMIA 1 0.0000
417 PULMONARY EMBOLISM 2 0.0000
418 MIGRAINE 2 0.0000
419 INFECTION 3 0.0000
420 DRUG INTOLERANCE 2 0.0000
421 HYPOAESTHESIA 3 0.0000
422 CELLULITIS 1 0.0000
423 BLOOD PRESSURE INCREASED 3 0.0000
424 ILLNESS 2 0.0000
425 ECZEMA 1 0.0000
426 NAUSEA 15 0.0000
427 BRADYCARDIA 1 0.0000
428 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
429 RASH PRURITIC 1 0.0000
430 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
431 MEDICATION ERROR 1 0.0000
432 WEIGHT DECREASED 5 0.0000
433 OXYGEN SATURATION DECREASED 1 0.0000
434 MYALGIA 3 0.0000
435 HERPES ZOSTER 1 0.0000
436 EYE IRRITATION 1 0.0000
437 CHILLS 2 0.0000
438 SURGERY 1 0.0000
439 NASAL CONGESTION 1 0.0000
440 JOINT SWELLING 2 0.0000
441 EMOTIONAL DISTRESS 2 0.0000
442 THERAPEUTIC RESPONSE DECREASED 1 0.0000
443 PLEURAL EFFUSION 1 0.0000
444 VERTIGO 1 0.0000
445 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
446 VISUAL IMPAIRMENT 2 0.0000
447 GAIT DISTURBANCE 3 0.0000
448 PRURITUS 6 0.0000
449 DEEP VEIN THROMBOSIS 1 0.0000
450 INSOMNIA 4 0.0000
451 INJECTION SITE PRURITUS 1 0.0000
452 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
453 MEMORY IMPAIRMENT 2 0.0000
454 BURNING SENSATION 1 0.0000
455 INJURY 1 0.0000
456 DEATH 12 0.0000
457 UNDERDOSE 1 0.0000
458 PAIN IN EXTREMITY 4 0.0000
459 BRONCHITIS 1 0.0000
460 WEIGHT INCREASED 3 0.0000
461 HOT FLUSH 1 0.0000
462 CARDIAC ARREST 1 0.0000
463 ABDOMINAL DISCOMFORT 2 0.0000
464 SKIN EXFOLIATION 1 0.0000
465 CEREBROVASCULAR ACCIDENT 2 0.0000
466 BALANCE DISORDER 1 0.0000
467 RASH 5 0.0000
468 MYOCARDIAL INFARCTION 2 0.0000
469 INTENTIONAL PRODUCT MISUSE 1 0.0000
470 MUSCULOSKELETAL STIFFNESS 1 0.0000
471 DRUG WITHDRAWAL SYNDROME 1 0.0000
472 PAIN 7 0.0000
473 GASTROINTESTINAL DISORDER 1 0.0000
474 DEVICE ISSUE 1 0.0000
475 ADVERSE DRUG REACTION 1 0.0000
476 MUSCLE SPASMS 2 0.0000
477 ADVERSE EVENT 1 0.0000
478 OROPHARYNGEAL PAIN 1 0.0000
479 COUGH 3 0.0000
480 SWELLING 1 0.0000
481 DYSPHAGIA 1 0.0000
482 SOMNOLENCE 2 0.0000
483 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
484 ABDOMINAL DISTENSION 1 0.0000
485 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
486 INFLUENZA 1 0.0000
487 ASTHMA 1 0.0000
488 RHEUMATOID ARTHRITIS 1 0.0000
489 DEPRESSION 2 0.0000
490 OFF LABEL USE 7 0.0000
491 HYPERHIDROSIS 1 0.0000
492 DRY SKIN 1 0.0000
493 PRODUCT QUALITY ISSUE 1 0.0000
494 ARTHRALGIA 3 0.0000
495 VOMITING 3 0.0000
496 DRUG DEPENDENCE 1 0.0000
497 DRUG DOSE OMISSION 1 0.0000
498 COVID-19 1 0.0000
499 NO ADVERSE EVENT 1 0.0000
500 NASOPHARYNGITIS 1 0.0000
501 BLOOD GLUCOSE INCREASED 1 0.0000
502 DYSPNOEA 3 0.0000
503 ALOPECIA 1 0.0000
504 HEADACHE 3 0.0000
505 OVERDOSE 1 0.0000
506 FEELING ABNORMAL 1 0.0000
507 PRODUCT DOSE OMISSION ISSUE 1 0.0000
508 INJECTION SITE PAIN 1 0.0000
509 DRUG INEFFECTIVE 4 0.0000